Pataigin
Pataigin develops advanced microbiology tests to identify disease pathogens and determine antimicrobial resistance. Their first product, BACLIB, is a rapid microbial identification test that detects pathogens in one hour directly from clinical samples. The company's mission is to make BACLIB a market-leading diagnostic tool that improves patient outcomes, reduces hospital expenses, and saves lives. Pataigin's science focuses on microbial lipids, using lipid fingerprinting technology to identify pathogens and resistance mechanisms rapidly and accurately.
Industries
Nr. of Employees
small (1-50)
Products
Rapid lipid-based microbial identification and susceptibility assay (research-use kit)
A rapid workflow and kit that performs on-target lipid extraction from clinical specimens, generates MALDI mass spectra of membrane lipids for species identification, and detects certain membrane-expressed resistance markers; includes software for identification and resistance determination. Intended for research use in current availability.
Rapid lipid-based microbial identification and susceptibility assay (research-use kit)
A rapid workflow and kit that performs on-target lipid extraction from clinical specimens, generates MALDI mass spectra of membrane lipids for species identification, and detects certain membrane-expressed resistance markers; includes software for identification and resistance determination. Intended for research use in current availability.
Services
Registration-based program providing research laboratories access to the rapid lipid-based identification and susceptibility assay for use in research applications (RUO); application does not guarantee access.
Registration-based program providing research laboratories access to the rapid lipid-based identification and susceptibility assay for use in research applications (RUO); application does not guarantee access.
Expertise Areas
- Lipidomics for microbial diagnostics
- Mass spectrometry-based pathogen identification
- Rapid antimicrobial susceptibility testing
- Direct-from-specimen diagnostic workflows
Key Technologies
- MALDI-TOF mass spectrometry
- On-target lipid extraction (FLAT)
- Isotopic labeling with deuterium (D2O) for growth detection
- Machine learning classification of mass spectra
News & Updates
Microbiology diagnostics company Pataigin appointed Deborah A. Elvins as an advisor on business strategy and other matters.
Results from a study of Pataigin’s rapid bacterial ID assay, direct from clinical specimens, will be presented at the European Congress of Clinical Microbiology & Infectious Diseases.
Pataigin announced the introduction of a multiplex lipid microbiology kit at the ECCMID conference.
The US NIH awarded Pataigin a research grant to further develop the Rigel antimicrobial susceptibility test.
This article discusses a lipid-based MALDI-TOF MS diagnostic for rapid detection of colistin resistance in Enterobacter species.
Microbiology diagnostics company Pataigin appointed Deborah A. Elvins as an advisor on business strategy and other matters.
Results from a study of Pataigin’s rapid bacterial ID assay, direct from clinical specimens, will be presented at the European Congress of Clinical Microbiology & Infectious Diseases.
Pataigin announced the introduction of a multiplex lipid microbiology kit at the ECCMID conference.
The US NIH awarded Pataigin a research grant to further develop the Rigel antimicrobial susceptibility test.
This article discusses a lipid-based MALDI-TOF MS diagnostic for rapid detection of colistin resistance in Enterobacter species.